Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.

Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. · 2017

Read Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States. by Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5879727.txt.

Introduction

Henley and co-authors compare cancer rates in rural and metro US counties. Their report appeared in MMWR Surveillance Summaries. Cancer data came from national registries and death records. Incidence was tracked from 2004 to 2013. Deaths were tracked from 2006 to 2015. Counties were split into rural, urban, and two metro classes. Rates were adjusted for age and split by cancer site.

Rural counties showed lower overall cancer incidence, they report. Yet their cancer death rates ran higher than metro areas. Death rates fell more slowly in nonmetro counties over the decade. That gap widened the rural disadvantage over time. Tobacco-linked cancers hit rural counties harder. So did cancers that screening can prevent.

Catalog record

CREATORHenley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5879727

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Invasive Cancer Incidence, 2004–2013, and Deaths, 2006–2015, in Nonmetropolitan and Metropolitan Counties — United States By S. Jane Henley, Robert N. Anderson, Cheryll C. Thomas, Greta M. Massetti, Brandy Peaker, Lisa C. Richardson Published in: MMWR Surveillance Summaries DOI: 10.15585/mmwr.ss6614a1 ABSTRACT Problem/Condition Previous reports have shown that persons living in nonmetropolitan (rural or urban) areas in the United States have higher death rates from all cancers combined than persons living in metropolitan areas. Disparities might vary by cancer type and between occurrence and death from the disease. This report provides a comprehensive assessment of cancer incidence and deaths by cancer type in nonmetropolitan and metropolitan counties. Reporting Period 2004–2015. Description of System Cancer incidence data from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results program were used to calculate average annual age-adjusted incidence rates for 2009–2013 and trends in annual age-adjusted incidence rates for 2004–2013. Cancer mortality data from the National Vital Statistics System were used to calculate average annual age-adjusted death rates for 2011–2015 and trends in annual age-adjusted death rates for 2006–2015. For 5-year average annual rates, counties were classified into four categories (nonmetropolitan rural, nonmetropolitan urban, metropolitan with population <1 million, and metropolitan with population ≥1 million). For the trend analysis, which used annual rates, these categories were combined into two categories (nonmetropolitan and metropolitan). Rates by county classification were examined by sex, age, race/ethnicity, U.S. census region, and cancer site. Trends in rates were examined by county classification and cancer site. Results During the most recent 5-year period for which data were available, nonmetropolitan rural areas had lower average annual age-adjusted cancer incidence rates for all anatomic cancer sites combined but higher death rates than metropolitan areas. During 2006–2015, the annual age-adjusted death rates for all cancer sites combined decreased at a slower pace in nonmetropolitan areas (-1.0% per year) than in metropolitan areas (-1.6% per year), increasing the differences in these rates. In contrast, annual age-adjusted incidence rates for all cancer sites combined decreased approximately 1% per year during 2004–2013 both in nonmetropolitan and metropolitan counties. Interpretation This report provides the first comprehensive description of cancer incidence and mortality in nonmetropolitan and metropolitan counties in the United States. Nonmetropolitan rural counties had higher incidence of and deaths from several cancers related to tobacco use and cancers that can be prevented by screening. Differences between nonmetropolitan and metropolitan counties in cancer incidence might reflect differences in risk factors such as cigarette smoking, obesity, and physical inactivity, whereas differences in cancer death rates might reflect disparities in access to health care and timely diagnosis and treatment. Public Health Action Many cancer cases and deaths could be prevented, and public health programs can use evidence-based strategies from the U.S. Preventive Services Task Force and Advisory Committee for Immunization Practices (ACIP) to support cancer prevention and control. The U.S. Preventive Services Task Force recommends population-based screening for colorectal, female breast, and cervical cancers among adults at average risk for these cancers and for lung cancer among adults at high risk; screening adults for tobacco use and excessive alcohol use, offering counseling and interventions as needed; and using low-dose aspirin to prevent colorectal cancer among adults considered to be at high risk for cardiovascular disease based on specific criteria. ACIP recommends vaccination against cancer-related infectious diseases including human papillomavirus and hepatitis B virus. The Guide to Community Preventive Services describes program and policy interventions proven to increase cancer screening and vaccination rates and to prevent tobacco use, excessive alcohol use, obesity, and physical inactivity. INTRODUCTION Cancer rates vary by many different characteristics, including geographic classifications such as county of residence. County populations differ from one another on the basis of demographic, environmental, economic, and social characteristics, which might influence the magnitude and types of health problems, including cancer (1). Counties can be classified as metropolitan or nonmetropolitan as defined by the Office of Management and Budget (2). This classification scheme can be further categorized by using the U.S. Department of Agriculture Economic Research Service (USDA ERS) rural-urban continuum codes classification scheme, which categorizes metropolitan counties by the population size of their metropolitan area and nonmetropolitan counties by degree of urbanization and adjacency to a metropolitan area (3). Previous research indicates that although cancer death rates decreased from 1999 to 2014 among all counties, decreases were slower in nonmetropolitan areas than metropolitan areas, increasing disparities (1). Comparisons of cancer death rates in nonmetropolitan areas and metropolitan areas have been described previously but not systematically assessed (1,4). The Healthy People 2020 initiative established a set of goals and objectives designed to improve the health of the U.S. population, recognizing the important role played by determinants of health, such as geographic location (5). As of 2017, Healthy People 2020 includes objectives for reducing age-adjusted overall cancer death rates to 161.4 deaths per 100,000 persons, lung cancer to 45.5 deaths per 100,000 persons, female breast cancer to 20.7 deaths per 100,000 females, cervical cancer to 2.2 deaths per 100,000 females, colorectal cancer to 14.5 deaths per 100,000 persons, oral cavity and pharynx cancer to 2.3 deaths per 100,000 persons, prostate cancer to 21.8 deaths per 100,000 males, and melanoma to 2.4 deaths per 100,000 persons (5). Healthy People 2020 also includes objectives to reduce age-adjusted incidence rates of colorectal cancer to 39.9 cases per 100,000 persons, late-stage breast cancer to 42.2 cases per 100,000 females, and cervical cancer to 7.3 cases per 100,000 females (5). This report assesses differences in cancer incidence and death rates by county classification, age group, sex, race/ethnicity, U.S. census region, and cancer type (and stage for incidence of cancers that are detectable by screening), as well as changes over time in incidence and death rates for common cancers in nonmetropolitan and metropolitan counties and whether these trends differ. In addition, this report assesses progress toward reaching the Healthy People 2020 objectives for cancer (5). These findings can be used by public health officials to identify areas with the highest rates of cancer incidence or mortality and focus on regions that might benefit from strategies to prevent cancer from occurring or to reduce deaths from cancer. METHODS To examine differences in cancer incidence and mortality in nonmetropolitan and metropolitan counties in the United States, CDC analyzed cancer incidence data from CDC’s National Program of Cancer Registries (NPCR) and the National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) program and cancer mortality data from the National Vital Statistics System (NVSS) (6,7). The most recent data available are through 2013 for incidence and through 2015 for deaths. This report presents average annual age-adjusted rates for the most recent 5-year period with available data (2009–2013 for incidence and 2011–2015 for deaths) and trends in annual age-adjusted incidence rates for the most recent 10-year period with available data (2004–2013 for incidence and 2006–2015 for deaths). For 5-year average annual rates, counties were classified into four categories (nonmetropolitan rural, nonmetropolitan urban, metropolitan with population <1 million, and metropolitan with population ≥1 million). For the trend analysis, which used annual rates, these categories were combined into two categories (nonmetropolitan and metropolitan). Incidence Data Data on new cases of cancer diagnosed during 2004–2013 were obtained from population-based

Read the complete text